Past Events

NCC for MATCA has received the highest rating of the TA CR panel

Abstract

The NCC for MATCA (National Centre of Competence for Materials, Advanced Technologies, Coatings and their Applications) co-financed with the Technology Agency of the Czech Republic’s (TA CR) state support within the National Centres of Competence Programme, has received the highest possible rating from the TA CR panel for the first phase of its existence lasting from 2019 to the end of 2022.

Dvořák Lecture by Marko Topič

Abstract

In the quest for a sustainable and decarbonized future, renewable energy sources have emerged as the key pillars of modern energy systems. Solar photovoltaic offers a vision of a world powered by 100% renewable electricity, where access to electricity is universal. It plays a vital role in meeting various energy demands, from communication and transportation to heating and synthetic fuels. Marko Topič's lecture covered several topics related to solar cells and photovoltaics.

Miloš Lokajíček Jr.

Abstract

Our friend and colleague, Miloš Lokajíček, PhD, CSc., long-standing staff member of the Division of Elementary Particle Physics at the Institute of Physics of the CAS, passed away at the age of 70 on Wednesday, June 14th. Miloš was involved in almost all the key experiments in which we participated and contributed significantly to them, especially in the field of acquisition and processing of experimental data.

Nuclear fusion with lasers and related science

Abstract

Renowned physicist Luca Volpe recently gave a lecture at FZU, discussing the latest breakthroughs in nuclear fusion with lasers and related science. The lecture, entitled “From the recent breakthrough at the National Ignition Facility (NIF) to a new European Pathway for Laser-Fusion in EU,” covered two main topics.

Drug induced liver injury - FZU hosted a debate about a serious problem

Abstract

Active substances of drugs, alone or in combination with each other, herbs and herbal supplements are metabolized by the human liver. This metabolization can be associated with irreversible damage or even death of the patient. There is no effective prevention against this problem. Additionally, there is no simple drug testing preclinical system to decipher hepatotoxicity issues undoubtfully at early stages of the drug development.